Photo from wikipedia
http://rehabilitation.cochrane. org The aim of this commentary is to discuss the Cochrane Review “Tocilizumab for giant cell arteritis”1 by Antonio et al,a published by Cochrane Eyes and Vision Group. This… Click to show full abstract
http://rehabilitation.cochrane. org The aim of this commentary is to discuss the Cochrane Review “Tocilizumab for giant cell arteritis”1 by Antonio et al,a published by Cochrane Eyes and Vision Group. This Cochrane Corner is produced in agreement with the International Journal of Rheumatic Diseases by Cochrane Rehabilitation with views* of the review summary author in the "implications for practice" section.
Keywords:
cochrane review;
cochrane;
giant cell;
review summary;
cell arteritis
Journal Title: International Journal of Rheumatic Diseases
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: International Journal of Rheumatic Diseases
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!